Brits are searching for weight-loss injections more frequently, with the UK seeing a staggering 4,049.74% surge since January ...

TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030, indicating ...

Obesity extends far beyond carrying extra weight - it represents a chronic condition affecting millions globally. While ...

Comparatively, obesity rates in most European countries remain below 25 percent, with some nations, particularly in Southern ...

Keeping kids healthy can be a big job. From the day their children are born, parents ferry them to and from medical offices, getting their immune systems boosted, teeth cleaned, eyes checked and ...

Sulforaphane, a compound found in broccoli sprouts, may help lower blood sugar levels in people with prediabetes, a new study ...

Because almost no existing programs focus specifically on reducing ultra-processed food (UPF) intake, researchers recently designed an intervention that included a variety of tactics to target the ...

Researchers at the American Cancer Society are more than a third of the way through their largest current study on cancer and they say they've already gathered valuable information. The Cancer ...

In Robert F. Kennedy Jr.’s first interview as secretary of the Department of Health and Human Services, he made multiple ...

Dr. Cheryl Kendall discusses urgent pediatric health concerns, offering solutions for childhood obesity and digital addiction ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...